Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions - PubMed

Affiliations

• PMID: 22924434
• DOI: 10.1021/jm300915b

Review

Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions

David S Hewings et al. J Med Chem. 2012.

Abstract

Bromodomains, protein modules that recognize and bind to acetylated lysine, are emerging as important components of cellular machinery. These acetyl-lysine (KAc) "reader" domains are part of the write-read-erase concept that has been linked with the transfer of epigenetic information. By reading KAc marks on histones, bromodomains mediate protein-protein interactions between a diverse array of partners. There has been intense activity in developing potent and selective small molecule probes that disrupt the interaction between a given bromodomain and KAc. Rapid success has been achieved with the BET family of bromodomains, and a number of potent and selective probes have been reported. These compounds have enabled linking of the BET bromodomains with diseases, including cancer and inflammation, suggesting that bromodomains are druggable targets. Herein, we review the biology of the bromodomains and discuss the SAR for the existing small molecule probes. The biology that has been enabled by these compounds is summarized.

Similar articles

• Small molecule inhibitors of bromodomain-acetyl-lysine interactions.

  Brand M, Measures AR, Wilson BG, Cortopassi WA, Alexander R, Höss M, Hewings DS, Rooney TP, Paton RS, Conway SJ. Brand M, et al. ACS Chem Biol. 2015 Jan 16;10(1):22-39. doi: 10.1021/cb500996u. ACS Chem Biol. 2015. PMID: 25549280 Review.

• Bromodomains as therapeutic targets.

  Muller S, Filippakopoulos P, Knapp S. Muller S, et al. Expert Rev Mol Med. 2011 Sep 13;13:e29. doi: 10.1017/S1462399411001992. Expert Rev Mol Med. 2011. PMID: 21933453 Free PMC article. Review.

• Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.

  Olp MD, Zhu N, Smith BC. Olp MD, et al. Biochemistry. 2017 Oct 17;56(41):5485-5495. doi: 10.1021/acs.biochem.7b00595. Epub 2017 Oct 5. Biochemistry. 2017. PMID: 28945351 Free PMC article.

• Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.

  Romero FA, Taylor AM, Crawford TD, Tsui V, Côté A, Magnuson S. Romero FA, et al. J Med Chem. 2016 Feb 25;59(4):1271-98. doi: 10.1021/acs.jmedchem.5b01514. Epub 2015 Dec 1. J Med Chem. 2016. PMID: 26572217

• The bromodomain: from epigenome reader to druggable target.

  Sanchez R, Meslamani J, Zhou MM. Sanchez R, et al. Biochim Biophys Acta. 2014 Aug;1839(8):676-85. doi: 10.1016/j.bbagrm.2014.03.011. Epub 2014 Mar 28. Biochim Biophys Acta. 2014. PMID: 24686119 Free PMC article. Review.

Cited by

• Identification of novel bromodomain inhibitors of Trypanosoma cruzi bromodomain factor 2 (TcBDF2) using a fluorescence polarization-based high-throughput assay.

  Tavernelli LE, Alonso VL, Peña I, Rodríguez Araya E, Manarin R, Cantizani J, Martin J, Salamanca J, Bamborough P, Calderón F, Gabarro R, Serra E. Tavernelli LE, et al. Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0024324. doi: 10.1128/aac.00243-24. Epub 2024 Jul 19. Antimicrob Agents Chemother. 2024. PMID: 39028190 Free PMC article.

• Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics.

  Jung KY, Wang H, Teriete P, Yap JL, Chen L, Lanning ME, Hu A, Lambert LJ, Holien T, Sundan A, Cosford ND, Prochownik EV, Fletcher S. Jung KY, et al. J Med Chem. 2015 Apr 9;58(7):3002-24. doi: 10.1021/jm501440q. Epub 2015 Mar 30. J Med Chem. 2015. PMID: 25734936 Free PMC article.

• Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.

  Theodoulou NH, Bamborough P, Bannister AJ, Becher I, Bit RA, Che KH, Chung CW, Dittmann A, Drewes G, Drewry DH, Gordon L, Grandi P, Leveridge M, Lindon M, Michon AM, Molnar J, Robson SC, Tomkinson NC, Kouzarides T, Prinjha RK, Humphreys PG. Theodoulou NH, et al. J Med Chem. 2016 Feb 25;59(4):1425-39. doi: 10.1021/acs.jmedchem.5b00256. Epub 2015 Apr 30. J Med Chem. 2016. PMID: 25856009 Free PMC article.

• Small Molecule Ligands of the BET-like Bromodomain, SmBRD3, Affect Schistosoma mansoni Survival, Oviposition, and Development.

  Schiedel M, McArdle DJB, Padalino G, Chan AKN, Forde-Thomas J, McDonough M, Whiteland H, Beckmann M, Cookson R, Hoffmann KF, Conway SJ. Schiedel M, et al. J Med Chem. 2023 Dec 14;66(23):15801-15822. doi: 10.1021/acs.jmedchem.3c01321. Epub 2023 Dec 4. J Med Chem. 2023. PMID: 38048437 Free PMC article.

• Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors.

  Ember SW, Zhu JY, Olesen SH, Martin MP, Becker A, Berndt N, Georg GI, Schönbrunn E. Ember SW, et al. ACS Chem Biol. 2014 May 16;9(5):1160-71. doi: 10.1021/cb500072z. Epub 2014 Mar 13. ACS Chem Biol. 2014. PMID: 24568369 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • American Chemical Society

• Other Literature Sources

  • The Lens - Patent Citations Database

• Chemical Information

  • BindingDB

• Miscellaneous

  • NCI CPTAC Assay Portal